75Indexed trials
mesh condition
Bipolar Disorder
Intelligence
Bipolar Disorder intelligence: 75 indexed trials, 17 recruiting studies, 56 sponsors across 38 countries.
17Recruiting
56Sponsors
38Countries
Leading sponsors
Massachusetts General Hospital40 recruiting
University Hospitals Cleveland Medical Center31 recruiting
University of Calgary20 recruiting
Sumitomo Pharma America, Inc.20 recruiting
University Hospital, Montpellier22 recruiting
Eli Lilly and Company20 recruiting
National Institute of Mental Health (NIMH)20 recruiting
New York State Psychiatric Institute20 recruiting
Otsuka Pharmaceutical Development & Commercialization, Inc.20 recruiting
Sandoz20 recruiting
Sunnybrook Health Sciences Centre20 recruiting
University of California, Los Angeles21 recruiting
Geographic activity
United States39trials
France10trials
Canada5trials
Russia5trials
Brazil4trials
China4trials
Czechia3trials
Japan3trials
India3trials
Denmark3trials
Spain3trials
Chile2trials
Leading interventions
Lurasidone3trials
Depakote 500 mg DR Tablets (Abbott Laboratories, USA)2trials
Lithium2trials
Divalproex Sodium 500 mg DR Tablets (Sandoz Inc., USA)2trials
Antidepressant1trials
Antipsychotic1trials
Add-on citalopram following optimized methylphenidate1trials
Aripiprazole1trials
Anti-inflammatory diet module1trials
Asenapine1trials
BHV-70001trials
Apolipoprotein (ApoE) detection1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.